Novelion Therapeutics is headquartered in Vancouver, British Columbia.
Novelion Therapeutics disclosed revenue of 130M USD for 2018 and 138M USD for 2017.
Novelion Therapeutics is a medical products company.
Novelion Therapeutics was founded in 1981.
1800-510 West Georgia Street,
Vancouver, British Columbia
V6B 0M3
United Kingdom,
(877) 764-3131
www.novelion.com
Novelion Therapeutics is a biotechnology company dedicated to the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. We are focused on developing our synthetic retinoid program for the treatment of certain inherited retinal diseases. Novelion Therapeutics was founded in 1981 and is based in Vancouver, Canada.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | 4 | - | - | - | - | - | 4 |
| vol | $855M | $855M | ||||||
| Sell (0.0/yr) | # | 1 | - | - | - | - | - | 1 |
| 5 | ||||||||
| Financial | Deals |
|---|---|
|
Greenhill & Co. |
1 |
| Legal | Deals |
|---|---|
|
Weil Gotshal & Manges |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
